CRBU
Price
$1.80
Change
-$0.12 (-6.25%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
190.92M
30 days until earnings call
Intraday BUY SELL Signals
MGX
Price
$1.32
Change
+$0.05 (+3.94%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
47.81M
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs MGX

CRBU vs MGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. MGX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CRBU: $1.92 vs. MGX: $1.27)
Brand notoriety: CRBU and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 103% vs. MGX: 199%
Market capitalization -- CRBU: $178.53M vs. MGX: $49.62M
CRBU [@Biotechnology] is valued at $178.53M. MGX’s [@Biotechnology] market capitalization is $49.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while MGX’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 6 bearish.
  • MGX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CRBU and MGX are a bad buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а +5.77% price change this week, while MGX (@Biotechnology) price change was +0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2026.

MGX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($191M) has a higher market cap than MGX($47.8M). CRBU YTD gains are higher at: 21.069 vs. MGX (-21.605). MGX has higher annual earnings (EBITDA): -87.55M vs. CRBU (-116.43M). MGX has more cash in the bank: 140M vs. CRBU (118M). CRBU has less debt than MGX: CRBU (26.9M) vs MGX (39.2M). MGX has higher revenues than CRBU: MGX (22.3M) vs CRBU (11.2M).
CRBUMGXCRBU / MGX
Capitalization191M47.8M400%
EBITDA-116.43M-87.55M133%
Gain YTD21.069-21.605-98%
P/E RatioN/AN/A-
Revenue11.2M22.3M50%
Total Cash118M140M84%
Total Debt26.9M39.2M69%
TECHNICAL ANALYSIS
Technical Analysis
CRBUMGX
RSI
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 28 days ago
80%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 26 days ago
88%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYRCX43.900.40
+0.92%
Rydex Retailing C
NMFAX17.880.08
+0.45%
Nationwide BNY Mellon Dyn US Core A
JATTX30.26N/A
N/A
Janus Henderson Triton T
NPSGX22.68N/A
N/A
Nicholas Partners Small Cap Gr Instl
MSCDX20.47-0.06
-0.29%
MassMutual Small Cap Opps R5

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-0.77%
EDIT - CRBU
65%
Loosely correlated
-1.21%
CRSP - CRBU
58%
Loosely correlated
-5.31%
SANA - CRBU
54%
Loosely correlated
-2.04%
RXRX - CRBU
53%
Loosely correlated
-5.32%
BEAM - CRBU
51%
Loosely correlated
-8.77%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with EDIT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+0.79%
EDIT - MGX
49%
Loosely correlated
-1.21%
CRBU - MGX
48%
Loosely correlated
-0.77%
VYGR - MGX
47%
Loosely correlated
-6.52%
PRME - MGX
47%
Loosely correlated
-10.64%
RXRX - MGX
46%
Loosely correlated
-5.32%
More